Steven Knapper

Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

Nicolas Goardon, Emanuele Marchi, Ann Atzberger et al. · Cancer Cell · 2011 · 640 citations · Full text

Life Sciences, Cell Biology, Oncology +14

Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · The Lancet Oncology · 2015 · 543 citations

Medicine, Hematology, Oncology +8

A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy

Steven Knapper, Alan K. Burnett, Tim Littlewood et al. · Blood · 2006 · 413 citations · Full text

Medicine, Oncology, Pharmacology +10

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

Takashi Sato, Xiaochuan Yang, Steven Knapper et al. · Blood · 2011 · 258 citations · Full text

Medicine, Oncology, Pharmacology +9

Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide

Claire Harrison, Adam J. Mead, Anesh Panchal et al. · Blood · 2017 · 167 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +3